Dyne Therapeutics, Inc.DYNNASDAQ
Loading
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q4 2025 | 0.00% |
| Q3 2025 | 21.65% |
| Q2 2025 | 7.62% |
| Q1 2025 | -19.32% |
| Q4 2024 | 8.33% |
| Q3 2024 | -37.14% |
| Q2 2024 | 13.58% |
| Q1 2024 | 25.69% |
| Q4 2023 | -10.10% |
| Q3 2023 | 8.33% |
| Q2 2023 | -44.00% |
| Q1 2023 | -5.63% |
| Q4 2022 | 8.97% |
| Q3 2022 | 22.77% |
| Q2 2022 | -46.38% |
| Q1 2022 | 31.00% |
| Q4 2021 | -20.48% |
| Q3 2021 | -43.10% |
| Q2 2021 | -16.00% |
| Q1 2021 | 21.88% |
| Q4 2020 | -106.45% |
| Q3 2020 | -40.91% |
| Q2 2020 | 64.52% |
| Q1 2020 | -47.62% |
| Q4 2019 | 8.70% |
| Q3 2019 | 39.47% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2017 | -962.20% |
| Q3 2017 | 55.19% |
| Q2 2017 | -149.59% |
| Q1 2017 | 361.70% |
| Q4 2016 | 28.79% |
| Q3 2016 | 70.93% |
| Q2 2016 | -7940.14% |
| Q1 2016 | 92.08% |
| Q4 2015 | -463.16% |
| Q3 2015 | -106.17% |
| Q2 2015 | 315.38% |
| Q1 2015 | -276.54% |